BAJAJ BROKING

Notification
No new Notification messages
Ather Energy IPO is Open!
Apply for the Ather Energy IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

539470

SHREEGANES

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

Shree Ganesh Biotech (India) L Share Price Update

As of the latest trading session, Shree Ganesh Biotech (India) L share price is currently at ₹ 0.89, which is down by ₹ -0.03 from its previous closing. Today, the stock has fluctuated between ₹ 0.89 and ₹ 0.92. Over the past year, Shree Ganesh Biotech (India) L has achieved a return of -24.59 %. In the last month alone, the return has been 2.22 %. Read More...

Shree Ganesh Biotech (India) L fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    35.50

  • P/E Ratio (TTM)

    18.40

  • Beta

    0.29

  • Book Value / share

    1.59

  • Return on equity

    0.99%

  • EPS (TTM)

    0.05

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    0.77

info icon alternate text

Shree Ganesh Biotech (India) L Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 14.41
Operating Expense 13.94
Net Profit 0.77
Net Profit Margin (%) 5.34
Earnings Per Share (EPS) 0.02
EBITDA 0.77
Effective Tax Rate (%) 0.00
Particulars SEP 2024 (Values in Cr)
Revenue 1.98
Operating Expense 1.96
Net Profit 0.32
Net Profit Margin (%) 16.16
Earnings Per Share (EPS) 0.01
EBITDA 0.32
Effective Tax Rate (%) 0.00
Particulars JUN 2024 (Values in Cr)
Revenue 3.56
Operating Expense 3.69
Net Profit 0.24
Net Profit Margin (%) 6.74
Earnings Per Share (EPS) 0.01
EBITDA 0.24
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 3.78
Operating Expense 4.30
Net Profit 0.54
Net Profit Margin (%) 14.28
Earnings Per Share (EPS) 0.01
EBITDA 0.54
Effective Tax Rate (%) 0.00
Particulars DEC 2023 (Values in Cr)
Revenue 4.12
Operating Expense 4.04
Net Profit 0.09
Net Profit Margin (%) 2.18
Earnings Per Share (EPS) 0.00
EBITDA 0.09
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 20.28
Operating Expense 20.48
Net Profit 0.62
Net Profit Margin (%) 3.05
Earnings Per Share (EPS) 0.02
EBITDA 0.85
Effective Tax Rate (%) 27.05
Particulars MAR 2023 (Values in Cr)
Revenue 62.45
Operating Expense 60.31
Net Profit 2.04
Net Profit Margin (%) 3.26
Earnings Per Share (EPS) 0.05
EBITDA 2.71
Effective Tax Rate (%) 25.09
Particulars MAR 2022 (Values in Cr)
Revenue 72.64
Operating Expense 69.20
Net Profit 2.53
Net Profit Margin (%) 3.48
Earnings Per Share (EPS) 0.13
EBITDA 3.50
Effective Tax Rate (%) 27.71
Particulars MAR 2021 (Values in Cr)
Revenue 17.21
Operating Expense 16.51
Net Profit 0.32
Net Profit Margin (%) 1.85
Earnings Per Share (EPS) 0.02
EBITDA 0.43
Effective Tax Rate (%) 25.58
Particulars MAR 2020 (Values in Cr)
Revenue 2.47
Operating Expense 2.24
Net Profit 0.24
Net Profit Margin (%) 9.71
Earnings Per Share (EPS) 0.12
EBITDA 0.24
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share 1.58
ROE % 0.99
ROCE % 1.36
Total Debt to Total Equity 0.00
EBITDA Margin 4.24
Particulars MAR 2023 (Values in Cr)
Book Value / Share 1.56
ROE % 3.33
ROCE % 4.43
Total Debt to Total Equity 0.00
EBITDA Margin 4.34
Particulars MAR 2022 (Values in Cr)
Book Value / Share 3.03
ROE % 4.28
ROCE % 5.92
Total Debt to Total Equity 0.00
EBITDA Margin 4.82
Particulars MAR 2021 (Values in Cr)
Book Value / Share 29.00
ROE % 0.92
ROCE % 1.23
Total Debt to Total Equity 0.00
EBITDA Margin 4.13
Particulars MAR 2020 (Values in Cr)
Book Value / Share 28.84
ROE % 0.42
ROCE % 0.42
Total Debt to Total Equity 0.00
EBITDA Margin 9.72
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.42
Total Assets 73.62
Total Liabilities 73.62
Total Equity 62.97
Share Outstanding 398624000
Price to Book Ratio 0.66
Return on Assets (%) 0.84
Return on Capital (%) 0.99
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.48
Total Assets 79.52
Total Liabilities 79.52
Total Equity 62.35
Share Outstanding 398624000
Price to Book Ratio 0.65
Return on Assets (%) 2.56
Return on Capital (%) 3.27
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.03
Total Assets 93.55
Total Liabilities 93.55
Total Equity 60.31
Share Outstanding 199312000
Price to Book Ratio 3.07
Return on Assets (%) 2.69
Return on Capital (%) 4.19
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.02
Total Assets 74.62
Total Liabilities 74.62
Total Equity 57.79
Share Outstanding 19931200
Price to Book Ratio 4.09
Return on Assets (%) 0.42
Return on Capital (%) 0.55
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.01
Total Assets 64.71
Total Liabilities 64.71
Total Equity 57.47
Share Outstanding 19931200
Price to Book Ratio 4.51
Return on Assets (%) 0.36
Return on Capital (%) 0.41
Particulars MAR 2024 (Values in Cr)
Net Income 0.85
Cash from Operations 10.39
Cash from Investing -10.20
Cash from Financing 0.00
Net change in Cash -0.05
Free Cash Flow 10.39
Particulars MAR 2023 (Values in Cr)
Net Income 2.71
Cash from Operations 11.21
Cash from Investing -10.09
Cash from Financing 0.00
Net change in Cash 0.44
Free Cash Flow 11.21
Particulars MAR 2022 (Values in Cr)
Net Income 3.49
Cash from Operations 4.54
Cash from Investing -3.36
Cash from Financing -0.19
Net change in Cash 0.01
Free Cash Flow 4.54
Particulars MAR 2021 (Values in Cr)
Net Income 0.42
Cash from Operations 2.47
Cash from Investing -2.35
Cash from Financing 0.00
Net change in Cash 0.00
Free Cash Flow 2.47
Particulars MAR 2020 (Values in Cr)
Net Income 0.23
Cash from Operations -1.00
Cash from Investing 0.98
Cash from Financing 0.00
Net change in Cash -0.02
Free Cash Flow -1.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 37.10 19.95 2.02 284.31 34.11 / 77.70
BLISS GVS PHARMA LTD 122.65 16.07 1.27 1292.37 92.25 / 184.95
CIPLA LTD 1541.00 24.94 4.38 124457.39 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 272.25 22.56 2.76 801.26 145.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 2904.45 57.61 29.41 49203.14 1924.30 / 3147.45
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 37.10 22.35 6.30 284.31 34.11 / 77.70
AMRUTAJAN HEALTH LTD 679.10 39.81 6.59 1963.32 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 8795.90 131.18 32.36 21989.75 5000.00 / 9199.00
BLISS GVS PHARMA LTD 122.65 15.93 1.26 1292.37 92.25 / 184.95

Shree Ganesh Biotech (India) L Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
0.89 -3.26 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 0.90
  • 26 Days 0.90
  • 10 Days 0.90
  • 50 Days 1.00
  • 12 Days 0.90
  • 100 Days 1.00
  • 20 Days 0.90
  • 200 Days 1.00
0.92 PIVOT

First Support

0.91

First Resistance

0.94

Second Support

0.89

Second Resistance

0.95

Third Support

0.88

Third Resistance

0.97

RSI

40.81

ADX

12.32

MACD

-0.01

Williams % R

-50.00

Commodity Channel Index (CCI)

-59.57

Date

2025-04-29

Week

453743.00

Same Day

279474.00

Month

433751.00

1 Year

0.30

3 Year

0.46

Over 1 Month

2.22%

down

Over 1 Year

-24.59%

down

Over 3 Months

-2.12%

down

Over 3 Years

-39.33%

down

Over 6 Months

-12.38%

down

Over 5 Years

-32.17%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

Shree Ganesh Biotech (India) L shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
98.57%
Promoter Holdings
0.0%
FII
1.42%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
New Era Fund Limited 5664940.0 (1.42%) Public Shareholding

News

Left Arrow
Right Arrow

Shree Ganesh Biotech (India) L corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
28 Apr 2022 27 Apr 2022 1:1
Ex-Date Old FV NEW FV Record Date
10 Feb 2022 10.0 1.0 11 Feb 2022

Shree Ganesh Biotech (India) L Share Price

Shree Ganesh Biotech India Limited was incorporated on September 2, 1982, as 'S.P. Commercial Co. Limited' under the Registrar of Companies, West Bengal. The Company has got the Certificate of Commencement of Business on September 14, 1982 from the Registrar of Companies, West Bengal. The Company was incorporated with an object to carry on the business of builders, Contractors and to deal in property and also to do investment and finance business.

In 2010, pursuant to a Scheme of Amalgamation, Shree Ganesh Bio-Tech (India) Private Limited was merged with S.P. Commercial Co. Limited pursuant to the order of the Hon'ble High at Calcutta dated February 15, 2010. The entire business of Shree Ganesh Bio-Tech (India) Private Limited consisting of trading and distribution of seeds were transferred to S.P. Commercial Co. Limited. Subsequently, Shree Ganesh Bio-Tech (India) Private Limited was dissolved pursuant to the said Scheme of Amalgamation and the name of the Company was changed to Shree Ganesh Bio-Tech (India) Limited. The name of the Company was changed to Shree Ganesh Bio-Tech (India) Limited and a fresh Certificate of Incorporation upon the change of name dated March 7, 2011 was issued by the Registrar of Companies, West Bengal.

The Company is presently engaged in the business of production, processing and marketing of high quality hybrid seeds for different crops like corn, sunflower, cotton, paddy, grain sorghum, etc.

Parent organization Indian Private
NSE symbol [-]
Founded 1982
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Shree Ganesh Biotech India Ltd?

Answer Field

The share price of Shree Ganesh Biotech India Ltd for NSE is ₹ 0.00 and for BSE is ₹ 0.89.

What is the Market Cap of Shree Ganesh Biotech India Ltd?

Answer Field

The market cap of Shree Ganesh Biotech India Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 35.50 Cr. as of now.

What is the 52 Week High and Low of Shree Ganesh Biotech India Ltd?

Answer Field

The 52 Week High and Low of Shree Ganesh Biotech India Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 1.44 and ₹ 0.83.

How to Buy Shree Ganesh Biotech India Ltd share?

Answer Field

You can trade in Shree Ganesh Biotech India Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Shree Ganesh Biotech India Ltd?

Answer Field

The 1 year returns on the stock has been -24.59%.

What is the Current Share Price of Shree Ganesh Biotech India Ltd?

Answer Field

Shree Ganesh Biotech India Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 0.89 as on Apr 30 2025 03:29 PM.

What is the Market Cap of Shree Ganesh Biotech India Ltd Share?

Answer Field

The market cap of Shree Ganesh Biotech India Ltd for NSE ₹ 0.0 & for BSE ₹ 35.50 as on Apr 30 2025 03:29 PM.

What is the P/E Ratio of Shree Ganesh Biotech India Ltd Share?

Answer Field

As on Apr 30 2025 03:29 PM the price-to-earnings (PE) ratio for Shree Ganesh Biotech India Ltd share is 18.40.

What is the PB ratio of Shree Ganesh Biotech India Ltd Share?

Answer Field

As on Apr 30 2025 03:29 PM, the price-to-book (PB) ratio for Shree Ganesh Biotech India Ltd share is 1.59.

How to Buy Shree Ganesh Biotech India Ltd Share?

Answer Field

You can trade in Shree Ganesh Biotech India Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Shree Ganesh Biotech India Ltd Share on Bajaj Broking App?

Answer Field

To buy Shree Ganesh Biotech India Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Shree Ganesh Biotech India Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|